Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 3/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 4/20 | 0.30 |
| ▸ | CES1 | P23141 | 4/20 | 0.30 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28366942 | 1.00 | BHMT (0.36) | BHMTCES2GMNNTP53POLB | |
| SCHEMBL31520214 | 1.00 | BHMT (0.36) | BHMTCES2GMNNTP53POLB | |
| SCHEMBL8578846 | 0.88 | TDP1 (0.32) | BHMT | |
| SCHEMBL20916744 | 0.82 | FOLH1 (0.32) | TRPV1TRPA1 | |
| SCHEMBL20916752 | 0.82 | FOLH1 (0.32) | TRPV1TRPA1 | |
| SCHEMBL31520215 | 0.82 | FOLH1 (0.32) | TRPV1TRPA1 | |
| SCHEMBL541720 | 0.80 | TRPV1 (0.40) | GMNNTP53POLBMAPTBLM | |
| SCHEMBL21624976 | 0.80 | TRPV1 (0.40) | GMNNTP53POLBMAPTBLM | |
| SCHEMBL8735841 | 0.80 | TRPV1 (0.40) | GMNNTP53POLBMAPTBLM | |
| SCHEMBL8777953 | 0.80 | TRPV1 (0.40) | GMNNTP53POLBMAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11560445-B2 | Silylated polyurethanes and methods for preparing thereof | HENKEL AG & CO. KGAA (DE) | 2023-01-24 | — | — | US | disclosed |
| EP-3498748-B1 | SILYLATED POLYURETHANES AND METHODS FOR PREPARING THEREOF | HENKEL AG & CO KGAA (DE) | 2022-02-02 | — | — | EP | disclosed |
| US-11078323-B2 | Silane coupling agents | HENKEL AG & CO. KGAA (DE) | 2021-08-03 | — | — | US | disclosed |
| EP-3655452-B1 | SILYLATED POLYURETHANES AND METHODS FOR PREPARING THEREOF | HENKEL AG & CO KGAA (DE) | 2021-07-07 | — | — | EP | disclosed |
| US-10889682-B2 | Silylated polyurethanes and methods for preparing thereof | HENKEL AG & CO. KGAA (DE) | 2021-01-12 | — | — | US | disclosed |
| US-20200299450-A1 | Silylated Polyurethanes and Methods for Preparing Thereof | HENKEL AG & CO. KGAA (DE) | 2020-09-24 | — | — | US | disclosed |
| EP-3655452-A1 | SILYLATED POLYURETHANES AND METHODS FOR PREPARING THEREOF | Henkel AG & Co. KGaA (DE) | 2020-05-27 | — | — | EP | disclosed |
| US-20200148808-A1 | Silylated Polyurethanes and Methods for Preparing Thereof | HENKEL AG & CO. KGAA (DE) | 2020-05-14 | — | — | US | disclosed |
| EP-3395847-B1 | SILANE COUPLING AGENTS | HENKEL AG & CO KGAA (DE) | 2020-03-11 | — | — | EP | disclosed |
| US-20200048406-A1 | Silane Coupling Agents | HENKEL AG & CO. KGAA (DE) | 2020-02-13 | — | — | US | disclosed |
| EP-3395847-A1 | SILANE COUPLING AGENTS | Henkel AG & Co. KGaA (DE) | 2018-10-31 | — | — | EP | disclosed |
| US-8609800-B2 | Curable compositions containing silylated polyurethanes | HENKEL AG & CO. KGAA (DE) | 2013-12-17 | — | — | US | disclosed |
| US-20130280530-A1 | TWO-COMPONENT CURABLE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2013-10-24 | — | — | US | disclosed |
| US-8563675-B2 | Curable compositions composed of silanes with two hydrolyzable groups | HENKEL AG & CO. KGAA (DE) | 2013-10-22 | — | — | US | disclosed |
| US-20130274414-A1 | CURABLE COMPOSITION HAVING A SPECIAL CATALYST/SOFTNER SYSTEM | HENKEL AG & CO. KGAA (DE) | 2013-10-17 | — | — | US | disclosed |
| US-20120055105-A1 | ADHESIVES AND SEALANTS BASED ON SILANE-TERMINATED BINDERS FOR BONDING AND SEALING FLEXIBLE SOLAR FILMS/PHOTOVOLTAIC MODULES | HENKEL AG & CO. KGAA (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20110071254-A1 | CURABLE COMPOSITIONS CONTAINING SILYLATED POLYETHER BLOCK POLYMER-BASED POLYURETHANES | HENKEL AG & CO. KGAA (DE) | 2011-03-24 | — | — | US | disclosed |
| US-20110034627-A1 | CURABLE COMPOSITIONS CONTAINING SILYLATED POLYURETHANES | HENKEL AG & CO. KGAA (DE) | 2011-02-10 | — | — | US | disclosed |
| US-20100204387-A1 | CURABLE COMPOSITIONS COMPOSED OF SILANES WITH TWO HYDROLYZABLE GROUPS | HENKEL AG & CO. KGAA (DE) | 2010-08-12 | — | — | US | disclosed |
| US-20100143712-A1 | SILANE-CROSSLINKING ADHESIVE OR SEALANT COMPRISING N-SILYLALKYLAMIDES AND USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11078323-B2 | Silane coupling agents | MACF1, SEPTIN8, ICAM1 | BHMT 1685/4885CES2 2173/4885GMNN 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.